Valerie Schmelter
Ludwig-Maximilians-Universität München, LMU Klinikum, GTx (United States)
Papers
7
Total Citations
72
H-Index
6
About
Valerie Schmelter is a leading clinical researcher in ocular oncology, with a focused expertise in the application of robotic-assisted radiosurgery for the treatment of intraocular tumors. Her work centers on the use of CyberKnife technology as a precise, non-invasive alternative to traditional therapies like plaque brachytherapy and enucleation. Schmelter’s major contributions include pioneering studies on the efficacy and safety of this technique for a range of conditions, from small choroidal melanomas and ciliary body melanomas to the rare iris melanoma and benign vasoproliferative tumors. Her most cited paper (2023, 27 citations) established the viability of CyberKnife radiosurgery for choroidal and ciliary body melanoma, while her subsequent work (2022, 11 citations) critically analyzed risk factors for local recurrence, a key determinant of patient survival. Through a series of retrospective reviews, she has systematically documented visual outcomes, complication profiles, and tumor control rates, providing essential data that helps refine treatment planning parameters. Schmelter’s research is instrumental in expanding stereotactic radiosurgery as a standard-of-care option, offering patients a globe-sparing treatment that minimizes collateral damage while effectively managing both malignant and vision-threatening benign tumors.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4Robotic CyberKnife radiosurgery for small choroidal melanomas7 citations · 2022
- 5
- 6Robotic CyberKnife Radiosurgery for Ciliary Body Melanoma6 citations · 2020
- 7